8 DSG-PEG2000 for Sale
DSG-PEG | ChemExpress
-
CAS No.:
308805-39-2
-
Packaging:
100g
DSG-PEG 2000.
-
CAS No.:
308805-39-2
-
Packaging:
1g/bag
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
DSG-PEG5000
-
CAS No.:
308805-39-2
-
Content:
95%
-
Packaging:
1g/BOTTLE
DSG-PEG 2000
-
CAS No.:
308805-39-2
Products You May Be Interested in
- (3S)-1,2,3,4-Tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid for sale
- 1-(4-amino-3,5-dichlorophenyl)-2-(dimethylamino)ethanol for sale
- Malonyl coenzyme A lithium saltCAS:108347-84-8Purity: 90% (HPLC) for sale
- BOC-GLU(OBZL)-OSU for sale
- 5-benzyl-2-(4-methylphenyl)sulfonyl-2,5-diazabicyclo[2.2.1]heptane for sale
308805-39-2 | ChemExpress
-
CAS No.:
308805-39-2
-
Packaging:
100g
DSG-PEG2000
-
CAS No.:
308805-39-2
-
Content:
95%
-
Packaging:
1g/BOTTLE
- Finding Semaglutide for sale in large quantity of choices all on www.echemi.com. Suppliers of 8 Semaglutide registered will be verified by the accurate information. To make sure the safety of the transaction on ECHEMI, we will make sure the information is trust-worthy of each supplier. We help you get chemicals in need continuously and meet registered Semaglutide suppliers.
- Semaglutide 910463-68-2 from ECHEMI are quality guaranteed. Our business partners are with certification, quanlification and so on. Semaglutide will reach global regulation and requirement of various regions. Further services on the whole supply chain can be provided with ECHEMI.
- We are providing better products and services of Semaglutide with fair price and reasonable deal. Services of Semaglutide like trade data and market price and insight can be subscribed on ECHEMI. ECHEMI provides the whole supply chain services to with efficient online options. ECHEMI is helping you of Semaglutide with global procurement service.
- •After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
- •The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
- •Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
- •Torrent Pharma Targets First Wave Semaglutide Launch Revenue Up 11 Percent as Patent Ends
- •New Trial Shows 62 Percent MASH Reversal with Semaglutide as $32 Billion Market Heats Up
-
Zhuhai Gene-Biocon Biological Technology Co., Ltd.
-
BANKPEPTIDE LTD
-
BrightGene Health Technology Co., Ltd
-
First Rays Co.,Ltd
-
Dongguan Chenguang Technology Co., Ltd.
-
Maintain Biotech Co.Ltd
-
Hangzhou Go Top Peptide Biotech Co.,Ltd.
-
Synpeptide Co., Ltd
-
Arshine Group Co., Ltd.
-
Dingwang Technology (Wuhan) Co., Ltd.